Literature DB >> 23027712

Impact of pre-analytical factors on the proteomic analysis of formalin-fixed paraffin-embedded tissue.

Seonaid M Thompson1, Rachel A Craven, Niroshini J Nirmalan, Patricia Harnden, Peter J Selby, Rosamonde E Banks.   

Abstract

Formalin-fixed paraffin-embedded (FFPE) tissue samples represent a tremendous potential resource for biomarker discovery, with large numbers of samples in hospital pathology departments and links to clinical information. However, the cross-linking of proteins and nucleic acids by formalin fixation has hampered analysis and proteomic studies have been restricted to using frozen tissue, which is more limited in availability as it needs to be collected specifically for research. This means that rare disease subtypes cannot be studied easily. Recently, improved extraction techniques have enabled analysis of FFPE tissue by a number of proteomic techniques. As with all clinical samples, pre-analytical factors are likely to impact on the results obtained, although overlooked in many studies. The aim of this review is to discuss the various pre-analytical factors, which include warm and cold ischaemic time, size of sample, fixation duration and temperature, tissue processing conditions, length of storage of archival tissue and storage conditions, and to review the studies that have considered these factors in more detail. In those areas where investigations are few or non-existent, illustrative examples of the possible importance of specific factors have been drawn from studies using frozen tissue or from immunohistochemical studies of FFPE tissue.
© 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23027712     DOI: 10.1002/prca.201200086

Source DB:  PubMed          Journal:  Proteomics Clin Appl        ISSN: 1862-8346            Impact factor:   3.494


  17 in total

1.  Quantification of HER2 by Targeted Mass Spectrometry in Formalin-Fixed Paraffin-Embedded (FFPE) Breast Cancer Tissues.

Authors:  Carine Steiner; Jean-Christophe Tille; Jens Lamerz; Sabine Kux van Geijtenbeek; Thomas A McKee; Miro Venturi; Laura Rubbia-Brandt; Denis Hochstrasser; Paul Cutler; Pierre Lescuyer; Axel Ducret
Journal:  Mol Cell Proteomics       Date:  2015-07-06       Impact factor: 5.911

Review 2.  Turning omics data into therapeutic insights.

Authors:  Amanda Kedaigle; Ernest Fraenkel
Journal:  Curr Opin Pharmacol       Date:  2018-08-24       Impact factor: 5.547

Review 3.  Tutorial: best practices and considerations for mass-spectrometry-based protein biomarker discovery and validation.

Authors:  Ernesto S Nakayasu; Marina Gritsenko; Paul D Piehowski; Yuqian Gao; Daniel J Orton; Athena A Schepmoes; Thomas L Fillmore; Brigitte I Frohnert; Marian Rewers; Jeffrey P Krischer; Charles Ansong; Astrid M Suchy-Dicey; Carmella Evans-Molina; Wei-Jun Qian; Bobbie-Jo M Webb-Robertson; Thomas O Metz
Journal:  Nat Protoc       Date:  2021-07-09       Impact factor: 17.021

4.  Proteomic sample preparation from formalin fixed and paraffin embedded tissue.

Authors:  Jacek R Wiśniewski
Journal:  J Vis Exp       Date:  2013-09-02       Impact factor: 1.355

5.  MALDI imaging mass spectrometry profiling of N-glycans in formalin-fixed paraffin embedded clinical tissue blocks and tissue microarrays.

Authors:  Thomas W Powers; Benjamin A Neely; Yuan Shao; Huiyuan Tang; Dean A Troyer; Anand S Mehta; Brian B Haab; Richard R Drake
Journal:  PLoS One       Date:  2014-09-03       Impact factor: 3.240

Review 6.  Applications of mass spectrometry for quantitative protein analysis in formalin-fixed paraffin-embedded tissues.

Authors:  Carine Steiner; Axel Ducret; Jean-Christophe Tille; Marlene Thomas; Thomas A McKee; Laura Rubbia-Brandt; Alexander Scherl; Pierre Lescuyer; Paul Cutler
Journal:  Proteomics       Date:  2014-03       Impact factor: 3.984

Review 7.  "Omics"-Informed Drug and Biomarker Discovery: Opportunities, Challenges and Future Perspectives.

Authors:  Holly Matthews; James Hanison; Niroshini Nirmalan
Journal:  Proteomes       Date:  2016-09-12

8.  Reproducible proteomics sample preparation for single FFPE tissue slices using acid-labile surfactant and direct trypsinization.

Authors:  Melanie Christine Föll; Matthias Fahrner; Victor Oginga Oria; Markus Kühs; Martin Lothar Biniossek; Martin Werner; Peter Bronsert; Oliver Schilling
Journal:  Clin Proteomics       Date:  2018-03-06       Impact factor: 3.988

9.  Analytical validation of the Immunoscore and its associated prognostic value in patients with colon cancer.

Authors:  Florence Marliot; Xiaoyi Chen; Amos Kirilovsky; Thomas Sbarrato; Carine El Sissy; Luciana Batista; Marc Van den Eynde; Nacilla Haicheur-Adjouri; Maria-Gabriela Anitei; Ana-Maria Musina; Viorel Scripcariu; Christine Lagorce-Pagès; Fabienne Hermitte; Jérôme Galon; Jacques Fieschi; Franck Pagès
Journal:  J Immunother Cancer       Date:  2020-05       Impact factor: 13.751

10.  Residual tissue repositories as a resource for population-based cancer proteomic studies.

Authors:  Paul D Piehowski; Vladislav A Petyuk; Ryan L Sontag; Marina A Gritsenko; Karl K Weitz; Thomas L Fillmore; Jamie Moon; Hala Makhlouf; Rodrigo F Chuaqui; Emily S Boja; Henry Rodriguez; Jerry S H Lee; Richard D Smith; Danielle M Carrick; Tao Liu; Karin D Rodland
Journal:  Clin Proteomics       Date:  2018-08-03       Impact factor: 3.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.